Ropivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ropivacaine Hydrochloride Injection (injection) from Eugia US LLC with status Current. The shortage was first posted on 03/23/2018. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- Eugia US LLC
- Package NDC
- 55150-195-20
- Dosage Form
- Injection
- Presentation
- Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20)
- Initial Posting
- 03/23/2018
- Revised Date
Reason
Demand increase for the drug